Benjamin Burnett
Stock Analyst at Stifel
(2.94)
# 1,184
Out of 4,667 analysts
64
Total ratings
45.45%
Success rate
0.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $87.22 | +39.88% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $24.49 | +181.75% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $25.54 | +166.25% | 7 | Sep 10, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $60 → $59 | $47.26 | +24.84% | 5 | Aug 6, 2024 | |
| PGEN Precigen | Maintains: Buy | $7 → $10 | $0.84 | +1,095.17% | 3 | Jun 3, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $2.05 | +124.39% | 5 | May 14, 2024 | |
| IRON Disc Medicine | Maintains: Buy | $71 → $73 | $62.55 | +16.71% | 5 | Apr 8, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $10.68 | +438.39% | 4 | Apr 1, 2024 | |
| RPTX Repare Therapeutics | Maintains: Buy | $16 → $17 | $2.84 | +498.59% | 4 | Sep 25, 2023 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $57.07 | -17.65% | 3 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.14 | +207.13% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5.3 → $5 | $2.22 | +125.23% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $690 → $780 | $7.18 | +10,763.51% | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $1.00 | +2,300.00% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $1.95 | +720.51% | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $94 → $70 | $0.30 | +23,002.31% | 3 | Mar 27, 2020 |
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $87.22
Upside: +39.88%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $24.49
Upside: +181.75%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $25.54
Upside: +166.25%
CRISPR Therapeutics AG
Aug 6, 2024
Maintains: Hold
Price Target: $60 → $59
Current: $47.26
Upside: +24.84%
Precigen
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $0.84
Upside: +1,095.17%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $2.05
Upside: +124.39%
Disc Medicine
Apr 8, 2024
Maintains: Buy
Price Target: $71 → $73
Current: $62.55
Upside: +16.71%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $10.68
Upside: +438.39%
Repare Therapeutics
Sep 25, 2023
Maintains: Buy
Price Target: $16 → $17
Current: $2.84
Upside: +498.59%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $57.07
Upside: -17.65%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $8.14
Upside: +207.13%
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $2.22
Upside: +125.23%
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $7.18
Upside: +10,763.51%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $1.00
Upside: +2,300.00%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $1.95
Upside: +720.51%
Mar 27, 2020
Upgrades: Buy
Price Target: $94 → $70
Current: $0.30
Upside: +23,002.31%